PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33302036-0	2021	Paeoniflorin ameliorates experimental colitis by inhibiting gram-positive bacteria-dependent MDP-NOD2 pathway.	peoniflorin	0-12	nucleotide-binding oligomerization domain containing 2	Mus musculus	97-101	
33302036-3	2021	This work aims to demonstrate that Gram-positive bacteria may be an underlying cause of experimental colitis in mice through the muramyl dipeptide (MDP)-nucleotide-binding oligomerization domain-containing protein-2 (NOD2) pathway and paeoniflorin inhibits the pathway above to alleviate experimental colitis.	peoniflorin	235-247	nucleotide-binding oligomerization domain containing 2	Mus musculus	153-215	
33302036-7	2021	Paeoniflorin also inhibited mRNA and protein expression of MDP-NOD2 pathway components and decreased the levels of related inflammatory cytokines.	peoniflorin	0-12	nucleotide-binding oligomerization domain containing 2	Mus musculus	63-67	
33302036-9	2021	Overall, the results indicated that Gram-positive bacteria promote the occurrence of colitis via up-regulation of MDP-NOD2 pathway, and paeoniflorin is able to decrease the infiltration of Gram-positive bacteria in intestine and inhibit Gram-positive bacteria-dependent MDP-NOD2 pathway to alleviate mice colitis.	peoniflorin	136-148	nucleotide-binding oligomerization domain containing 2	Mus musculus	274-278